Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate Dosing Schedules for HPV Vaccine
NCT00862810Phase 4Completed
- Sponsor
- Duke University
- Start
- Mar 2009
- Primary completion
- Sep 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of qHPV vaccine in Cervical Cancer (CC), genital warts, sponsored by Duke University. Started Mar 2009; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
Cervical Cancer (CC)genital warts
Beyond the preview
Go deeper on NCT00862810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862810.